<i>In vitro</i>, mouse colonic organoids were utilized to examine the effects of baicalin and puerarin on inflammation-induced downregulation of Muc2 and ZO-1.<h4>Results</h4>MGQD therapy dramatically reduced the severity of colitis in both mouse models. This evidence concerns the gene MUC2 and colitis.